Adaptation of Coping Together - a self-directed coping skills intervention for patients and caregivers in an outpatient hematopoietic stem cell transplantation setting: a study protocol

BMC Health Services Research
Tammy SonCarmen G Loiselle

Abstract

Despite numerous reports of significant distress and burden for hematopoietic stem cell transplantation (HSCT) patients and caregivers (CGs), HSCT-specific coping interventions remain rare. The few in use lack specificity and are often not easily accessible or cost-effective. Whereas the development of new interventions is resource-intensive, theory-informed adaptation of existing evidence-based interventions is promising. To date, no HSCT-specific intervention has relied on a formal adaptation approach. Using the Center for Disease Control and Prevention's Map of Adaptation, this two-phase qualitative descriptive study seeks to understand the perceptions of HSCT patients, CGs, individually, and in dyads, and clinicians about Coping Together (CT) for the preliminary adaptation (Phase 1), and then explores perceptions of the modified intervention in additional mixed sample (Phase 2). Six to ten participants including outpatients, CGs and dyads and five to seven HSCT clinician participants will be recruited for Phase 1. For Phase 2, 14 to 16 participants including outpatients, CGs and dyads will be recruited. Individual and dyadic semi-structured interviews will take place between 100 and 130 days post-HSCT. Verbatim transcripts ...Continue Reading

References

Nov 20, 2002·Bone Marrow Transplantation·P FreyJ N Winter
Sep 22, 2006·AIDS Education and Prevention : Official Publication of the International Society for AIDS Education·Vel S McKleroyUNKNOWN ADAPT Team
Nov 8, 2006·Journal of Psychosocial Oncology·Deborah H EldredgePatricia G Archbold
Mar 21, 2008·Journal of Advanced Nursing·Satu Elo, Helvi Kyngäs
Dec 24, 2008·Bone Marrow Transplantation·B L FifeT E Stump
Feb 11, 2011·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Liz CookeLillian M Nail
Jun 10, 2011·Journal of Public Health Dentistry·Helen I Meissner
Jun 15, 2011·Journal of Family Psychology : JFP : Journal of the Division of Family Psychology of the American Psychological Association (Division 43)·Maureen MonaghanRandi Streisand
May 16, 2012·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Chien-Wen J ChoiPaula R Sherwood
Jul 14, 2012·Expert Opinion on Biological Therapy·Massimo MartinoAttilio Olivieri
Oct 23, 2012·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·J ArmoogumJ Armes
Feb 27, 2013·Psycho-oncology·Teresa L SimoneauMark L Laudenslager
Aug 21, 2013·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sylvie D LambertKaren Kayser
Aug 21, 2013·Journal of Family Psychology : JFP : Journal of the Division of Family Psychology of the American Psychological Association (Division 43)·Betsy L FifeTimothy T Stump
Mar 19, 2014·British Journal of Health Psychology·Marjan J TraaBrenda L Den Oudsten
Mar 26, 2014·Journal of Consulting and Clinical Psychology·Guy BodenmannThomas N Bradbury
Jul 18, 2014·Revista brasileira de hematologia e hemoterapia·Alessandra BarbanFrederico Luiz Dulley
Mar 19, 2015·Cancer Nursing·Diane Von AhBetsy Fife
Jul 18, 2015·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sylvie D LambertPeter Chong

❮ Previous
Next ❯

Software Mentioned

NVivo®
SPSS Statistics

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.